The 25,000-subject study is testing a nucleoside-modified mRNA (modRNA), quadrivalent vaccine that is targeted against four strains of the flu virus that the World Health Organization (WHO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback